Psoriatic Arthritis Trial, Recruiting (NCT07150000)

Psoriatic Arthritis Trial, Recruiting NCT07150000 Sponsor: University of Bonn Condition: Psoriatic Arthritis

Printed from Voxsanity (voxsanity.com.au) — NCT07150000 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Psoriatic Arthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You are willing to take part and able to sign a consent form agreeing to join the study
A doctor has confirmed you have one of the following conditions: rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis (a type of spinal inflammation), giant cell arteritis, lupus, systemic sclerosis (scleroderma), mixed connective tissue disease, inflammatory muscle disease, or one of several blood vessel inflammation conditions (microscopic polyangiitis, granulomatosis with polyangiitis, or eosinophilic granulomatosis with polyangiitis), or a periodic fever/autoinflammatory condition such as Familial Mediterranean fever, CAPS, TRAPS, or Adult-onset Still's disease

If you are joining as a healthy volunteer:

You are 18 years old or older and able to sign a consent form agreeing to join the study

Who may not be able to join:

You do not wish to take part in the study, or you are unable to sign a consent form giving your agreement

Healthy volunteers may not be able to join if:

You have a known or currently active rheumatological (joint or autoimmune) disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0049 228 287 17016

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07150000

Sponsor: University of Bonn

Phase: Not Applicable

Status: Recruiting

Condition: Psoriatic Arthritis

Trial contact: 0049 228 287 17016

More information: https://clinicaltrials.gov/study/NCT07150000

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You are willing to take part and able to sign a consent form agreeing to join the study
A doctor has confirmed you have one of the following conditions: rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis (a type of spinal inflammation), giant cell arteritis, lupus, systemic sclerosis (scleroderma), mixed connective tissue disease, inflammatory muscle disease, or one of several blood vessel inflammation conditions (microscopic polyangiitis, granulomatosis with polyangiitis, or eosinophilic granulomatosis with polyangiitis), or a periodic fever/autoinflammatory condition such as Familial Mediterranean fever, CAPS, TRAPS, or Adult-onset Still's disease

If you are joining as a healthy volunteer:

You are 18 years old or older and able to sign a consent form agreeing to join the study

Who may not be able to join:

You do not wish to take part in the study, or you are unable to sign a consent form giving your agreement

Healthy volunteers may not be able to join if:

You have a known or currently active rheumatological (joint or autoimmune) disease

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Bonn

Registry

ClinicalTrials.gov

Start date

1 April 2025

Est. completion

1 December 2028

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Changes in Immune Cell Phenotype in the Ex-Vivo Assay

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov